← Leaderboards
Max Brenner
Therasource, Llc
$5,242,481
Attributed
$8,995,201
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,995,201 · 8
By mechanism
U01$5,807,491 · 3
R44$1,997,541 · 1
R43$689,329 · 2
R41$333,340 · 1
R21$167,500 · 1
Top collaborators
- Ping Wang11 shared
- Monowar Aziz4 shared
- Haichao Wang2 shared
- Asha Varghese1 shared
Most similar at Therasource, Llc
Same institution · by research overlap
- Rongqian Wu$5,339,526
- Weng-Lang Yang$7,053,625
Others in their field
Other Emerging Leaders on “Public Health Relevance”
- Susan M Landau · University Of California Berkeley$47,252,026
- Timothy M Willson · University Of Cape Town$32,741,597
- Pamela Winer Goldberg · Medical Device Innovation Consortium$28,780,000
- George Robert Painter · University Of Alabama At Birmingham$25,957,440
- Oliver Brand · Emory University$14,091,647
- Maryellen Giger · University Of Chicago$14,002,824
Research focus
Public Health RelevanceDoseAttenuatedCellsMolecularMortalitySafetyRna-Binding ProteinsNovel TherapeuticsFda ApprovedKidneyInjuryLungAcuteLiverPatternBaseReceptorBloodRadiation Dose UnitIn VivoRadiation ExposureExposure ToRadiation
Grant awards (20)
Mechanisms of Radiation-Induced Innate Immune Dysfunction and Its Countermeasures$767,178
U01 · FY2025 · AI
Ghrelin as Radiation Countermeasure: Mechanism of Its Action$586,240
U01 · FY2025 · AI
MSP68 as an effective radiation countermeasure$167,500
R21 · FY2025 · AI · contact PI
Mechanisms of Radiation-Induced Innate Immune Dysfunction and Its Countermeasures$759,412
U01 · FY2024 · AI
Mechanisms of Radiation-Induced Innate Immune Dysfunction and Its Countermeasures$751,877
U01 · FY2023 · AI
eCIRP-Neutralizing mAb for Acute Lung Injury in Sepsis$129,820
R43 · FY2023 · AI · contact PI
Mechanisms of Radiation-Induced Innate Immune Dysfunction and Its Countermeasures$726,622
U01 · FY2022 · AI
Mechanisms of Radiation-induced Vascular Endothelial Cell Injury and Its Correction$563,604
U01 · FY2022 · AI
eCIRP-Neutralizing mAb for Acute Lung Injury in Sepsis$259,510
R43 · FY2022 · AI · contact PI
Mechanisms of Radiation-induced Vascular Endothelial Cell Injury and Its Correction$100,000
U01 · FY2022 · AI · contact PI
rhMFG-E8 as an Effective Adjuvant Therapy for Hemorrhagic Shock$986,433
R44 · FY2021 · HL · contact PI
Mechanisms of Radiation-induced Vascular Endothelial Cell Injury and Its Correction$565,254
U01 · FY2021 · AI
The Role of Ionizing Radiation in Alzheimerâs Disease$418,750
U01 · FY2021 · AI · contact PI
Mechanisms of Radiation-induced Vascular Endothelial Cell Injury and Its Correction$568,554
U01 · FY2020 · AI
rhMFG-E8 as an Effective Adjuvant Therapy for Hemorrhagic Shock$505,554
R44 · FY2020 · HL · contact PI
A New Therapy for Acute Kidney Injury$139,504
R43 · FY2020 · DK · contact PI
rhMFG-E8 as an Effective Adjuvant Therapy for Hemorrhagic Shock$505,554
R44 · FY2019 · HL · contact PI
A New Therapy for Acute Kidney Injury$160,495
R43 · FY2019 · DK · contact PI
Preclinical Development of a Novel Small Molecule Drug for Sepsis$111,168
R41 · FY2018 · GM · contact PI
Preclinical Development of a Novel Small Molecule Drug for Sepsis$222,172
R41 · FY2017 · GM · contact PI